glp 1 weight loss study Healthy maintenance with exercise, GLP-1 receptor agonist, or both combined followed by one year without treatment: a post-treatment analysis of a randomised placebo-controlled trial Key Facts GPs Should Know
Description
Examining trial-specific data is beyond the current scope, but we can gain summative insights from meta-analyses of these RCTs
Physiology 78 (1), 277299
Moderate Side Effects You Should Know Side effects are not mild in all instances
2002, 282, E873E879
Lancet 398 , 143155 (2021)
Regular monitoring and appropriate dose adjustment of levothyroxine to maintain TSH within the reference range (typically 0.4-4.0 mU/L, though individualised targets may apply) is essential before implementing additional weight management interventions
